West Pharmaceutical Services, Inc.
WST · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $3.07B | $2.89B | +6.3% |
| Operating income | $585M | $570M | +2.6% |
| Net income | $494M | $493M | +0.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $874M | $805M | +8.7% |
| Operating income | $267M | $168M | +59.5% |
| Net income | $214M | $140M | +52.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was West Pharmaceutical's revenue in FY2025?
- $3.07B in FY2025 (Fiscal year ended Dec 31, 2025), +6.3% vs $2.89B a year earlier, per its 10-K filed Feb 2026.
- Was West Pharmaceutical profitable in FY2025?
- Yes: net income was $494M and operating income $585M in FY2025.
- What was West Pharmaceutical's revenue in Q3 2026?
- $874M (+8.7% vs a year earlier), per its Form 10-Q filed Oct 29, 2026.